Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo

AIM: To evaluate the possibility of generation 4 polyamidoamine (G4PAMAM) dendrimers acting as the delivery system of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotides (VEGFASODN), and to investigate the anti-tumor effect of G4PAMAM/VEGFASODN complex on the cultured cells and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xin, Guo-Hong, Zhao, Xin-Han, Liu, Dong, Gong, Qiang, Hou, Lei, Li, Jing-Yun, Pan, Bo-Rong, Li, Xu, Cheng, Ya-Jie
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Journal of Ophthalmology Press 2012
Schlagworte:
Basic Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428538/
https://ncbi.nlm.nih.gov/pubmed/22937502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2012.04.07
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge